BAY2701438
/ Bayer
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
April 26, 2022
A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Protein
(clinicaltrials.gov)
- P1 | N=213 | Recruiting | Sponsor: Bayer | Trial completion date: Jul 2027 ➔ Jul 2028 | Trial primary completion date: Jul 2025 ➔ Jul 2026
Trial completion date • Trial primary completion date • Breast Cancer • Esophageal Cancer • Gastric Cancer • Gastrointestinal Cancer • HER2 Breast Cancer • Oncology • Solid Tumor • HER-2
August 25, 2021
A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Protein
(clinicaltrials.gov)
- P1; N=213; Recruiting; Sponsor: Bayer; Trial completion date: Sep 2026 ➔ Jul 2027; Trial primary completion date: Dec 2024 ➔ Jul 2025
Clinical • Trial completion date • Trial primary completion date • Breast Cancer • Esophageal Cancer • Gastric Cancer • Gastrointestinal Cancer • HER2 Breast Cancer • Oncology • HER-2
July 20, 2020
A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Protein
(clinicaltrials.gov)
- P1; N=176; Recruiting; Sponsor: Bayer; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Breast Cancer • Esophageal Cancer • Gastric Cancer • Gastrointestinal Cancer • HER2 Breast Cancer • Oncology • HER-2
April 21, 2020
A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Protein
(clinicaltrials.gov)
- P1; N=176; Not yet recruiting; Sponsor: Bayer; Initiation date: Mar 2020 ➔ Sep 2020
Clinical • Trial initiation date • Breast Cancer • Esophageal Cancer • Gastric Cancer • Gastrointestinal Cancer • HER2 Breast Cancer • Oncology • Solid Tumor • HER-2
1 to 4
Of
4
Go to page
1